Under TGFβ stimulation, CAFs release high levels of cytokines and chemokines, contributing to attracting neutrophils, macrophages, lymphocytes, and natural killer (NK) cells at the site of the tumor lesion, thus boosting the inflammatory response that favors cancer progression [16]. The gene discussed is TGFB1; the disease is neoplasm.